TBC1D21 Inhibitors
TBC1D21 inhibitors encompass a range of chemicals that target various signaling pathways and cellular processes, ultimately leading to the downregulation of TBC1D21's functional activity. For example, Wortmannin and LY294002 serve as potent inhibitors of the phosphoinositide 3-kinase (PI3K), which plays a critical role in membrane trafficking and cytoskeletal dynamics; inhibiting PI3K can thus indirectly affect TBC1D21 which is associated with these processes. Similarly, SB 203580 and PD 98059, which target p38 MAPK and MEK respectively, alter cellular stress responses and the MAPK/ERK pathway that could modulate the functional context within which TBC1D21 operates. Other compounds such as NSC 23766 and ML141 specifically inhibit the GTPases Rac1 and Cdc42, respectively, both of which are integral to actin cytoskeleton organization, indirectly influencing TBC1D21's involvement in membrane dynamics and trafficking.
Further inhibitors, like Go6976 and Y-27632, which target protein kinase C (PKC) and ROCK kinases, play roles in the regulation of vesicle formation and actin cytoskeleton arrangement. Their inhibition can create a cellular environment that indirectly leads to the functional impairment of TBC1D21, which is implicated in these processes. Spautin-1 and Brefeldin A, by disrupting autophagy and vesicle formation from the Golgi apparatus, could attenuate TBC1D21 activity through the perturbation of vesicular trafficking pathways. Additionally, Dynasore and Latrunculin A, by specifically targeting dynamin-related endocytosis and actin polymerization, propose an indirect inhibition mechanism by altering vesicle movement and trafficking, processes critical for TBC1D21 function. Collectively, these inhibitors represent a targeted approach to mitigate the functional activity of TBC1D21 by influencing the signaling pathways and cellular mechanisms that facilitate its role in the cell.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
This is a potent phosphoinositide 3-kinase (PI3K) inhibitor. Since PI3K is involved in membrane trafficking and cytoskeletal dynamics, its inhibition could lead to altered vesicular transport and membrane dynamics, thereby indirectly inhibiting TBC1D21, which is associated with regulation of membrane trafficking. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A pyridinyl imidazole compound acting as a specific inhibitor of p38 MAPK. The p38 MAPK pathway is involved in cellular stress responses; by blocking this pathway, the cellular processes that might regulate or modify the function of TBC1D21 could be compromised. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A chemical inhibitor of PI3Ks. By inhibiting PI3K, LY294002 could affect vesicle formation and trafficking, potentially reducing the functional involvement of TBC1D21 in these processes. | ||||||
NSC 23766 | 733767-34-5 | sc-204823 sc-204823A | 10 mg 50 mg | $151.00 $609.00 | 75 | |
Selectively inhibits Rac1 activation by preventing interaction with guanine nucleotide exchange factors (GEFs). As Rac1 is implicated in actin cytoskeleton organization, NSC 23766 could indirectly influence the function of TBC1D21 by altering the cytoskeleton dynamics. | ||||||
Gö 6976 | 136194-77-9 | sc-221684 | 500 µg | $227.00 | 8 | |
A potent protein kinase C (PKC) inhibitor. PKCs are involved in a variety of cellular functions including membrane trafficking. Inhibiting PKC can impact vesicle formation and, as a result, may indirectly inhibit TBC1D21 function. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
A selective inhibitor of ROCK kinases. Since ROCK is involved in actin cytoskeleton organization, Y-27632 could indirectly affect TBC1D21 function by altering the cytoskeleton, which is important for vesicle trafficking. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $137.00 $512.00 | 7 | |
A selective and reversible inhibitor of Cdc42 GTPase. By inhibiting Cdc42, ML141 could affect cytoskeletal organization and membrane trafficking, potentially impacting TBC1D21's role in these processes. | ||||||
Spautin-1 | 1262888-28-7 | sc-507306 | 10 mg | $168.00 | ||
An autophagy inhibitor that promotes the degradation of Vps34 PI3 kinase complexes. Since TBC1D21 is involved in membrane trafficking, the disruption of autophagy and vesicle formation could indirectly inhibit its function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
A selective inhibitor of MEK, which is part of the MAPK/ERK pathway. By inhibiting this pathway, PD 98059 could affect cellular processes that may regulate TBC1D21 function. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
A GTPase inhibitor that specifically targets dynamin, which is crucial for clathrin-mediated endocytosis. Inhibition of dynamin could disrupt endocytic pathways and vesicle trafficking, indirectly affecting TBC1D21. | ||||||